CADL Stock-Based Compensation
Candel Therapeutics Inc · Stock-Based Compensation
CADL Stock-Based Compensation
Latest reported$6.76Mperiod ending
CADL Stock-Based Comp ($400.00K → $6.76M)
Annual stock-based compensation
High-resolution chart · PNG
CADL stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 3,817,000 | |
| 5,312,000 | |
| 3,091,000 | |
| 2,307,000 | |
| 2,963,000 | |
| 2,107,000 | |
| 400,000 |